Psychedelics Psychedelic compound psilocybin shows promise for preventing chemo nerve damage A human trial called 'NeuroGuard' is expected to commence in November Rowan Dunne2 days ago
Health & Wellness Quest Diagnostics and University of Texas want to promote more cancer screenings Quest plans to refine, expand, and validate the MCaST technology for its own lab-developed test Joseph MortonJune 11, 2025